Publications

Found 16 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2022
Kashani AH, Lebkowski JS, Hinton DR, Zhu D, Faynus MA, Chen S, Rahhal FM, Avery RL, Salehi-Had H, Chan C et al..  2022.  Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.. Stem Cell Reports. 17(3):448-458.
Kashani AH, Lebkowski JS, Hinton DR, Zhu D, Faynus MA, Chen S, Rahhal FM, Avery RL, Salehi-Had H, Chan C et al..  2022.  Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.. Stem Cell Reports. 17(3):448-458.
2021
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Chen S, Chan C, Palejwala N, Ingram A, Dang W et al..  2021.  One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.. Transl Vis Sci Technol. 10(10):13.
2020
Kashani AH, Uang J, Mert M, Rahhal F, Chan C, Avery RL, Dugel P, Chen S, Lebkowski J, Clegg DO et al..  2020.  Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.. Ophthalmol Retina. 4(3):264-273.
2018
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin C-M, Mitra D, Zhu D, Thomas BB et al..  2018.  A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.. Science Translational Medicine. 10(435)
2012
Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, Diniz B, Thomas PB, Ahuja AK, Hinton DR, Tai Y-C et al..  2012.  A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Research. 48(4):186-91.
2011
Ahuja A, Clegg D, Grubbs R, Hinton D, Humayun M, Tai YC.  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
Humayun M, Ahuja A, Tai Y-C, Hinton D, Grubbs R, Clegg D, JOHNSON LVallance, Hikita ST, .  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
2009
Carr A-J, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LLi, Buchholz DE, Ahmado A, Semo M'ayan, Smart MJK et al..  2009.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 4(12):e8152.
2006
Hikita ST, Vistica BP, Jones HR, Keswani JR, Watson MM, Ericson VR, Ayoub GS, Gery I, Clegg DO.  2006.  Osteopontin is proinflammatory in experimental autoimmune uveitis. Investigative Ophthalmology & Visual Science. 47(10):4435-43.
2002
Clegg DO, Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH.  2002.  Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration. Investigative Ophtalmology & Visual Science. 43:697.
Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO.  2002.  Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration. Experimental Eye Research. 74(1):141-54.
2000
Clegg DO, Mullick LH, Wingerd KL, Lin H, Atienza JW, Bradshaw AD, Gervin DB, Cann GM.  2000.  Adhesive events in retinal development and function: the role of integrin receptors. Vertebrate Eye Development. :141–156.
1997
Lin H, Anderson DH, Johnson LV, Clegg DO.  1997.  Exposure of ROS to serum facilitates ROS phagocytosis by cultured human RPE. Investigative Ophthalmology & Visual Science. 38:1541–1541.
1995
Setty S, Anderson SS, Wayner EA, Kim Y, Clegg DO, Tsilibary EC.  1995.  Glucose-induced alteration of integrin expression and function in cultured human mesangial cells. Cell Communication and Adhesion. 3(3):187-200.
1993
Volpe P, Gorza L, Brini M, Sacchetto R, Ausoni S, Clegg DO.  1993.  Expression of the calsequestrin gene in chicken cerebellum Purkinje neurons. Biochemical Journal. 294 ( Pt 2):487-90.